PYXS
Pyxis Oncology Inc

2,531
Mkt Cap
$91.53M
Volume
188,119.00
52W High
$5.55
52W Low
$0.8332
PE Ratio
-0.92
PYXS Fundamentals
Price
$1.47
Prev Close
$1.54
Open
$1.54
50D MA
$1.54
Beta
1.32
Avg. Volume
479,145.24
EPS (Annual)
-$1.32
P/B
1.33
Rev/Employee
$366,954.54
$17.03
Loading...
Loading...
News
all
press releases
Pyxis Oncology (NASDAQ:PYXS) Lowered to Sell Rating by Wall Street Zen
Wall Street Zen cut shares of Pyxis Oncology from a "hold" rating to a "sell" rating in a research report on Sunday...
MarketBeat·7d ago
News Placeholder
More News
News Placeholder
Pyxis Oncology (PYXS) Projected to Post Quarterly Earnings on Tuesday
Pyxis Oncology (NASDAQ:PYXS) will be releasing its Q4 2025 earnings before the market opens on Tuesday, March 17. (View Earnings Report at...
MarketBeat·12d ago
News Placeholder
Pyxis Oncology (NASDAQ:PYXS) Upgraded at Wall Street Zen
Wall Street Zen upgraded shares of Pyxis Oncology from a "sell" rating to a "hold" rating in a report on Saturday...
MarketBeat·15d ago
News Placeholder
Pyxis Oncology, Inc. (NASDAQ:PYXS) Given Average Rating of "Moderate Buy" by Brokerages
Shares of Pyxis Oncology, Inc. (NASDAQ:PYXS - Get Free Report) have earned an average recommendation of "Moderate Buy" from the seven research firms that are covering the stock, MarketBeat reports...
MarketBeat·29d ago
News Placeholder
Pyxis Oncology, Inc. (NASDAQ:PYXS) Short Interest Update
Pyxis Oncology, Inc. (NASDAQ:PYXS - Get Free Report) saw a significant growth in short interest in January. As of January 15th, there was short interest totaling 2,307,831 shares, a growth of 33.1...
MarketBeat·2mo ago
News Placeholder
Pyxis Oncology, Inc. (NASDAQ:PYXS) Given Average Recommendation of "Moderate Buy" by Brokerages
Pyxis Oncology, Inc. (NASDAQ:PYXS - Get Free Report) has received an average recommendation of "Moderate Buy" from the seven research firms that are presently covering the firm, Marketbeat reports...
MarketBeat·2mo ago
News Placeholder
Pyxis Oncology (NASDAQ:PYXS) Downgraded by Wall Street Zen to "Sell"
Wall Street Zen lowered shares of Pyxis Oncology from a "hold" rating to a "sell" rating in a research note on Sunday...
MarketBeat·2mo ago
News Placeholder
Wall Street Zen Upgrades Pyxis Oncology (NASDAQ:PYXS) to "Hold"
Wall Street Zen upgraded shares of Pyxis Oncology from a "sell" rating to a "hold" rating in a research report on Saturday...
MarketBeat·2mo ago
News Placeholder
Pyxis Oncology, Inc. (NASDAQ:PYXS) Given Consensus Recommendation of "Moderate Buy" by Brokerages
Pyxis Oncology, Inc. (NASDAQ:PYXS - Get Free Report) has been assigned a consensus recommendation of "Moderate Buy" from the seven brokerages that are covering the firm, Marketbeat.com reports. One...
MarketBeat·3mo ago
News Placeholder
Short Interest in Pyxis Oncology, Inc. (NASDAQ:PYXS) Drops By 57.3%
Pyxis Oncology, Inc. (NASDAQ:PYXS - Get Free Report) was the recipient of a significant decline in short interest in the month of December. As of December 15th, there was short interest totaling...
MarketBeat·3mo ago
<
1
2
...
>

Latest PYXS News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.